News Daily News A Simple Nudge Moves the Needle on Statin Prescribing Michael O'Riordan December 02, 2022
News Daily News Cardiac Biomarkers Reflect Sex Hormones in Transgender People Caitlin E. Cox October 06, 2022
News Daily News Stable Chest Pain Guideline Data Standards Developed to Add Uniformity Yael L. Maxwell September 02, 2022
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Daily News New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill Shelley Wood August 23, 2022
News Daily News INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease Michael O'Riordan July 12, 2022
News Daily News FDA Plans to Slash Nicotine Levels in Cigarettes and Other Products Michael O'Riordan June 23, 2022
News Daily News Neurologic, Psychiatric Risks Linger Among Adult Cardiac Arrest Survivors Todd Neale June 03, 2022
News Conference News EAS 2022 FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses Michael O'Riordan May 26, 2022
News Daily News Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI Michael O'Riordan May 13, 2022
News Daily News Acute MI Workup in Emergency Departments Varies by Sex and Race Michael O'Riordan May 11, 2022
News Daily News Good News and Bad for High-Intensity Statin Use in ASCVD Michael O'Riordan May 05, 2022
News Daily News CVD Hospitalizations Spiked in Aftermath of 2020 US Election Michael O'Riordan April 22, 2022
News Conference News ACC 2022 APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study Michael O'Riordan April 03, 2022
News Daily News Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention Michael O'Riordan March 30, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022